Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02196051 · ClinicalTrials.gov registry record · NA
Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.
A NA study of Insulin Resistance, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT02196051: Completed NA study of Insulin Resistance, sponsored by Yale University.
NCT02196051 is a NA study of Insulin Resistance that has completed, run by Yale University. The registered enrollment target is 41 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02196051, a NA study of Insulin Resistance, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to examine the pathophysiology of insulin resistance and the relation to the metabolic syndrome in humans.
Primary Outcome
At the baseline assessment, de novo lipogenesis was assessed after a high carbohydrate meal and a drink of heavy water. Muscle glycogen and lipid contents were measured pre- and post meal using 1H/13C MRS and de novo lipogenesis was assessed from the heavy water incorporation into blood lipid in samples collected overnight.
Conditions Studied
Interventions
- OTHER one bout of 45 minutes exercise
Study Locations (1)
Connecticut
- YCCI/YNNH Hospital Research Unit - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2008-01-01 |
| Est. Completion | 2012-01-30 |
| Phase | NA |
What the finished NCT02196051 record still lists
NCT02196051 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which one bout of 45 minutes exercise is the first listed.
NCT02196051 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02196051 about?
NCT02196051 is a clinical study titled "Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.". The purpose of this study was to examine the pathophysiology of insulin resistance and the relation to the metabolic syndrome in humans.
What is the current status of trial NCT02196051?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2008-01-01. Estimated completion is 2012-01-30.
What conditions does trial NCT02196051 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT02196051?
The interventions under investigation include: one bout of 45 minutes exercise (OTHER).
Who is sponsoring clinical trial NCT02196051?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02196051 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02196051's enrollment target sits among peer trials
41 70th of 120 higher than 51 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI